 | Acorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to Buy
marketbeat.com - January 18 at 4:41 PM |
| Acorda Therapeutics (NASDAQ:ACOR) Upgraded by Zacks Investment Research to "Buy"
marketbeat.com - December 21 at 4:18 PM |
 | Dalfampridine Market 2021: Trends, Drivers, Strategies, Applications and Competitive Landscape 2026
marketwatch.com - January 20 at 7:26 PM |
 | Acorda Stock at $35 a Share? This Analyst Thinks It’s Possible
finance.yahoo.com - January 16 at 5:14 AM |
 | Acorda Therapeutics (NASDAQ:ACOR) Stock Price Up 5.2%
americanbankingnews.com - January 15 at 7:24 PM |
 | Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At ...
businesswire.com - January 15 at 7:06 AM |
| Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija
finance.yahoo.com - January 14 at 5:32 PM |
 | Stock Alert: Acorda Therapeutics Gains 50% On Plan To Sell INBRIJA
nasdaq.com - January 13 at 2:33 PM |
|
| Acorda Therapeutics (NASDAQ:ACOR) Price Target Raised to $35.00 at Cowen
americanbankingnews.com - January 13 at 2:24 PM |
| Acorda Therapeutics (NASDAQ:ACOR) Shares Gap Up to $4.24
americanbankingnews.com - January 13 at 11:54 AM |
 | Acorda Therapeutics, NuCana leads healthcare gainers; Zomedica, Forward Pharma among major losers
seekingalpha.com - January 13 at 11:03 AM |
| Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into "At The Market" Offering Agreement
finance.yahoo.com - January 13 at 8:50 AM |
| Acorda Therapeutics to Present at 39th Annual J.P. Morgan Health Care Conference
finance.yahoo.com - January 12 at 4:43 PM |
| Acorda Therapeutics to Present at H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 11 at 7:34 PM |
| Acorda Therapeutics (NASDAQ:ACOR) Trading Up 6.3%
americanbankingnews.com - January 5 at 8:56 PM |
| Comparing Acorda Therapeutics (NASDAQ:ACOR) and Editas Medicine (NASDAQ:EDIT)
americanbankingnews.com - January 5 at 7:16 AM |
| Bionano Genomics, Ocugen leads healthcare gainers; Calithera Biosciences, Acorda Therapeutics among major losers
seekingalpha.com - January 4 at 12:02 PM |
| Acorda Therapeutics Announces Completion of One-for-Six Reverse Stock Split
finance.yahoo.com - December 31 at 7:47 PM |
| Acorda Therapeutics completes 1-for-6 reverse stock split
seekingalpha.com - December 31 at 6:04 PM |
| Spinal Cord Trauma Treatment Market Size 2021 by Share, Market Dynamics, Company Overview and Investment Analysis Business Overview to 2024
marketwatch.com - December 23 at 1:10 PM |
| Is ACOR A Good Stock To Buy Now?
finance.yahoo.com - December 8 at 2:26 AM |
| Spinal Cord Trauma Treatment Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19
marketwatch.com - November 9 at 9:11 AM |
| Analysts Are More Bearish On Acorda Therapeutics, Inc. (NASDAQ:ACOR) Than They Used To Be
nasdaq.com - November 8 at 8:41 AM |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) Analysts Are Reducing Their Forecasts For Next Year
finance.yahoo.com - November 8 at 8:41 AM |
| Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 10:51 PM |
 | Acorda Therapeutics: Q3 Earnings Insights
benzinga.com - November 3 at 5:50 PM |
| Acorda Therapeutics EPS beats by $0.10, beats on revenue
seekingalpha.com - November 3 at 5:50 PM |
| Acorda Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 3 at 5:50 PM |
|
| The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
finance.yahoo.com - November 3 at 12:49 PM |
| Preview: Acorda Therapeutics's Earnings
finance.yahoo.com - November 2 at 6:03 PM |
| Acorda Third Quarter 2020 Update: Webcast/Conference Call Scheduled for November 3, 2020
finance.yahoo.com - October 27 at 8:05 AM |
| Acorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 26 at 5:44 PM |
| Looking Into Acorda Therapeutics's Return On Capital Employed
benzinga.com - October 22 at 10:24 PM |
| Why Acorda's Stock Is Trading Higher Today
benzinga.com - October 22 at 1:15 AM |
| Looking Into Acorda Therapeutics's Return On Capital Employed
finance.yahoo.com - October 20 at 5:37 PM |
| Why Acorda's Stock Is Trading Higher Today
finance.yahoo.com - October 20 at 5:37 PM |
| Acorda Therapeutics Inc. Regist (CDG.SG)
au.finance.yahoo.com - October 10 at 12:00 AM |
| Are Options Traders Betting on a Big Move in Acorda Therapeutics (ACOR) Stock?
nasdaq.com - September 29 at 1:19 PM |
| 4 Top Penny Stocks Reaching New Highs Today; 1 Up 60%+ In September
marketwatch.com - September 26 at 2:38 AM |
| Diclofenac Patches Market Top Key Players, Share, Capacity, Entry Strategies, Production and Production Value and Forecast 2020 to 2026
marketwatch.com - September 8 at 12:31 PM |
| Post herpetic Neuralgia Treatment Market 2020 Top Manufacturers, Industry Share, Size, Trends, Growth Factor and Forecast 2025
marketwatch.com - August 31 at 9:29 AM |
 | ACOR.OQ - Acorda Therapeutics Inc Profile | Reuters
reuters.com - August 20 at 3:54 AM |
| Acorda Therapeutics: Q2 Earnings Insights
finance.yahoo.com - August 5 at 1:53 AM |
| Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - July 31 at 2:34 PM |
| Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled for August 4, 2020
finance.yahoo.com - July 28 at 10:37 AM |
| Do Hedge Funds Love Acorda Therapeutics Inc (ACOR)?
finance.yahoo.com - July 8 at 8:18 PM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Acorda Therapeutics, Inc. - ACOR
finance.yahoo.com - June 16 at 7:09 PM |
| SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acorda Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - June 16 at 9:06 AM |
| Is the Options Market Predicting a Spike in Acorda Therapeutics (ACOR) Stock?
finance.yahoo.com - June 9 at 3:29 PM |
| Global Non-opioid Pain Patches Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026
www.marketwatch.com - June 7 at 9:46 AM |
| Acorda (ACOR) Down 11.8% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 4 at 1:05 PM |
| Cerebral Palsy Treatment Market Current Scenario; Who will Surpass | Allergan, Cellular Biomedicine, GlaxoSmithKline
www.marketwatch.com - June 3 at 9:44 AM |
